Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News

October 5, 2009 – Boston Scientific released its CE-marked, next-generation iLab System Software for the iLab ...

Home October 05, 2009
Home
News

October 5, 2009 - Philips Healthcare rolled out a new upgrade program for its Allura Xper family of cardiovascular ...

Home October 05, 2009
Home
Technology


Philips Healthcare offers the 3D Heart Navigator interventional tool, which combines 3D CT images of a patients’ ...

Home October 02, 2009
Home
News

October 1, 2009 – Flexible Stenting Solutions Inc. (FSS) said this week it received conditional investigational ...

Home October 01, 2009
Home
News

October 1, 2009 – The six-month clinical outcome of Sahajanand Medical Technologies Supralimus Sirolimus-Eluting ...

Home October 01, 2009
Home
News

October 1, 2009 – Invatec recently launched the REEF HP PTA Balloon Catheter at CIRSE 2009, which the company said ...

Home October 01, 2009
Home
News

October 1, 2009 – Spectranetics Corp. yesterday said it filed a 510(k) application with the U.S. Food and Drug ...

Home October 01, 2009
Home
News

September 30, 2009 – PLC Systems Inc. demonstrated its RenalGuard System to help prevent contrast-induced ...

Home September 30, 2009
Home
News

September 30, 2009 – Invatec this week at the European CIRSE 2009 conference launched its latest self-expanding ...

Home September 30, 2009
Home
News

September 30, 2009 – New clinical data released at TCT 2009 last week showed strong and sustained efficacy and ...

Home September 30, 2009
Home
News

September 30, 2009 - A new study published in the Society for Vascular Surgery's October 2009 issue of the ...

Home September 30, 2009
Home
bbott's XIENCE V Everolimus-Eluting Coronary Stent achieved superiority in the key safety and efficacy measures compared to the TAXUS Express Paclitaxel-Eluting Coronary Stent at one year in SPIRIT IV Trial.
Feature | Stents | Dave Fornell

September 29, 2009 – Among the biggest news to come out of TCT 2009 last week was the late-breaking data from the ...

Home September 30, 2009
Home
News

September 29, 2009 – Cordis Corp. and Boston Scientific announced late today they reached an agreement to resolve ...

Home September 29, 2009
Home
News

September 29, 2009 – Abiomed Inc. announced new clinical data last week at TCT 2009 from Academic Medical Center’s ...

Home September 29, 2009
Home
News

September 29, 2009 – Volcano Corp. released imaging results from PROSPECT Trial, which demonstrated the ...

Home September 29, 2009
Home
Subscribe Now